Cell and gene therapy access expands into community care settings only when operational coordination, site readiness, and supply chain standardization become first-order priorities equivalent to ...

After taking a lateral move that came with a pay cut under the promise that they would be next in line for promotion if they ...

Clinical data harmonization is the real bottleneck standing between life sciences companies and AI's transformative potential. The life sciences industry is navigating a pivotal transition in 2026.

THE ARTICLES ON THESE PAGES ARE PRODUCED BY BUSINESS REPORTER, WHICH TAKES SOLE RESPONSIBILITY FOR THE CONTENTS ...

When biotechnology innovators approach the commercialization cliff, market participants must weigh the clinical promise of a lead asset against the stark realities of surging operating expenses and ...

Paradigm Biopharma shares today moved from trading halt to suspension after the company delayed releasing its phase III knee ...

Zapata Quantum, Inc., a leader in quantum computing algorithm and application development, announced early access to Quantum Pilot, a hardware-agnostic, cloud-based software platform designed to close ...

Amid expanding research into and medical applications of human tissue ECM and growth in the related industry, the inaugural ...

Discover tardigrades, Earth's indestructible micro-animals! Explore their astonishing biology, from survival secrets to global habitats. Unpack the science ...

Researchers from the University of Glasgow will join international partners in a bid to transform how chronic inflammatory disease is treated.

Key Points Interested in Moderna, Inc.? Here are five stocks we like better. Moderna plans to pursue regulatory filing for intismeran, its personalized mRNA cancer vaccine developed with Merck, ...

The latest executive moves suggest a nutrition industry entering a more institutionalized and global phase of growth and professionalizing around scale, science and channel expansion.